Background The coronavirus disease 2019 (COVID‐19) pandemic has impacted healthcare
systems worldwide. Multiple reports on thromboembolic complications related to COVID‐19 …

We previously showed decellularized fish swim bladder can be used as vascular patch and
tube graft in rats, mesenchymal stem cells (MSCs) have showed the capability to inhibit …

Background There have been still limited data on the transition of management strategies
and clinical outcomes after introduction of direct oral anticoagulant (DOAC) for cancer …

Aims We investigated the incidence and clinical features of venous thromboembolism (VTE)
in inpatients with mental illnesses. Methods We retrospectively analyzed records of …

It has been shown that patients with cancer have a longer expected life duration, benefiting
from advanced medical therapy. Meanwhile, the risk of suffering from cardiovascular …

Whether the use of acid suppressants can reduce non-vitamin K oral anticoagulants
(NOACs)-related gastrointestinal bleeding (GIB) remains unclear. To systemically evaluate …

Objective To determine the association between the duration of systemic anticoagulation
therapy (ACT) and the risk of further venous thromboembolism (VTE) in patients with …

Background Ovarian vein resection (OVR) and ovarian vein embolization (OVE) are effective
options for treating patients with pelvic venous disorder (PeVD). However, due to in an …

Background Residual venous obstruction (RVO) is considered a risk factor of recurrence
and possibly other clinical outcomes following deep vein thrombosis (DVT). Current …

Acute iliofemoral deep vein thrombosis and chronic iliofemoral venous obstruction cause
substantial patient harm and are increasingly managed with endovascular venous …